Medco Extends URAC Accreditation to Drug Therapy Management, PBM
FRANKLIN LAKES, N.J., Dec. 28, 2010 /PRNewswire/ -- Medco Health Solutions, Inc., (NYSE: MHS) today announced that URAC, one of the nation's leading independent health care quality evaluators, has accredited Medco's Pharmacy Benefit Management and Drug Therapy Management (DTM) programs, recognizing the company's commitment to clinical quality and accountability to customers.
URAC conducted an extensive review evaluating more than 400 standards at Medco's Franklin Lakes, N.J., headquarters, as well individual call centers and the Medco Therapeutic Resource Centers® (TRCs). URAC surveyors evaluated a range of services such as Medco's RationalMed® patient safety system and its drug utilization review system. Medco's DTM programs include the TRCs – which provides access to Medco Specialist Pharmacists who are trained in helping patients with specific chronic and complex conditions – as well as the company's call center and front-end pharmacies.
Medco Specialist Pharmacists are changing the practice of pharmacy in the TRCs by offering patients with chronic diseases – such as asthma, diabetes, cancer, HIV, depression, cardiovascular disease or high cholesterol – focused and personalized care that is specific to their condition. Medco's research subsidiary, the Medco Research Institute™, is presenting and publishing data that demonstrates how specialized and personalized pharmacy intervention can help identify potential issues and improve outcomes for patients managing a chronic condition.
"Medco is leading a mission to make medicine smarter by advancing the field of pharmacy on multiple fronts. We are focused on advancing the skills of our clinicians, on leveraging technology